← back to database
The T1D Fund is a mission-driven venture philanthropy fund that co-invests globally from discovery through clinical-stage development in differentiated therapies and technologies with the potential to treat, prevent, or cure type 1 diabetes.
Stage focus
Lead / follow
Specialization
Generalist / Specialist
Specialist
Latest fund size
$250 million+ AUM
Latest fund vintage
2016
Investing team
Daniel Flicker, Ph.D.Principal
Lucio Iannone, Ph.D.Managing Director
Morgan Janes, Ph.D.Associate
Peyman HosseinchiSenior Associate
Sylvia Tobé, Ph.D.Managing Director
Valerie Su, Ph.D.Associate
Yash MalliwalSenior Analyst